Remote ischemic conditioning: A clinical trial's update

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 16, Issue 3-4, 2011, Pages 304-312

  Candilio, Luciano ^a   Hausenloy, Derek J ^a   Yellon, Derek M ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

ischemia reperfusion; preconditioning; remote preconditioning

Indexed keywords

ACUTE HEART INFARCTION; CONFERENCE PAPER; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART SURGERY; ISCHEMIC PRECONDITIONING; MULTICENTER STUDY (TOPIC); PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMOTE ISCHEMIC CONDITIONING; VASCULAR SURGERY;

CARDIOTONIC AGENTS; CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY;

EID: 80051501959     PISSN: 10742484     EISSN: 19404034     Source Type: Journal    
DOI: 10.1177/1074248411411711     Document Type: Conference Paper

References (78)

1. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med. 2007 ; 357 (11). 1121-1135
2. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003 ; 361 (9351). 13-20 (Pubitemid 36050955)
3. McManus D, Chinali M. Saczynski J, et al. 30-year trends in heart failure in patients hospitalized with acute myocardial infarction. Am J Cardiol. 2011 ; 107 (3). 353-359
4. Braunwald E, Kloner RA. The stunned myocardium: Prolonged, postischaemic ventricular dysfunction. Circulation. 1982 ; 66 (6). 1146-1149 (Pubitemid 13238825)
5. Krug A, Du Mesnil de R, Korb G. Blood supply of the myocardium after temporary coronary occlusion. Circ Res. 1966 ; 19 (1). 57-62
6. Ito H. No-reflow phenomenon and prognosis in patients with acute myocardial infarction. Nat. Clin Pract Cardiovasc Med. 2006 ; 3 (9). 499-506 (Pubitemid 44288463)
7. Manning AS, Hearse DJ. Reperfusion induced arrhythmias: mechanisms and prevention. J Mol Cell Cardiol. 1984 ; 16 (6). 497-518 (Pubitemid 15040732)
8. Hearse DJ, Humphrey SM, Chain EB. Abrupt reoxygenation of the anoxic potassium arrested perfused rat heart: a study of myocardial enzyme release. J Mol Cell Cardiol. 1973 ; 5 (4). 395-407
9. Lemasters JJ, Bond JM, Chacon E, et al. The pH paradox in ischaemia-reperfusion injury to cardiac myocytes. EXS. 1996 ; 76: 99-114
10. Piper HM, Garcia-Dorado D, Ovize M. A fresh look at reperfusion injury. Cardiovasc Res. 1998 ; 38 (2). 291-300 (Pubitemid 28294147)
11. Vinten-Johansen J. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc Res. 2004 ; 61 (3). 481-497 (Pubitemid 38210154)
12. Jonassen AK, Sack MN, Mjos OD, Yellon DM. Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circ Res. 2001 ; 89 (12). 1191-1198 (Pubitemid 34627878)
13. Hausenloy DJ, Yellon DM. The mitochondrial permeability transition pore: Its fundamental role in mediating cell death during ischaemia and reperfusion. J Mol Cell Cardiol. 2003 ; 35 (4). 339-341 (Pubitemid 36411694)
14. Ono H, Osanai T, Ishizaka H, et al. Nicorandil improves cardiac function and clinical outcome in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: role of inhibitory effect on reactive oxygen species formation. Am Heart J. 2004 ; 148 (4). E15
15. Ishii H, Ichimiya S, Kanashiro M, et al. Impact of a single intravenous administration of nicorandil before reperfusion in patients with ST-segment-elevation myocardial infarction. Circulation. 2005 ; 112 (9). 1284-1288 (Pubitemid 41266722)
16. Kitakaze M, Asakura M, Shintani Y, et al. Large-scale trial using atrial natriuretic peptide or nicorandil as an adjunct to percutanoeus coronary intervention for STsegment elevation acute myocardial infarction (American Heart Association Scientific Sessions. Chicago, Nov. 2006) Circ J. 2004 ; 68 (2). 95-100 (Pubitemid 38197243)
17. Zeymer U, Suryapranata H, Monassier JP, et al. The Na(+)/H(+) exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction: results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial. J Am Coll Cardiol. 2001 ; 38 (6). 1644-1650 (Pubitemid 33065449)
18. Bär FW, Tzivoni D, Dirksen MT, et al. Results of the first clinical study of adjunctive CAldaret (MCC-135) in patients undergoing primary percutaneous coronary intervention for ST-Elevation Myocardial Infarction: the randomised multicentre CASTEMI study. Eur Heart J. 2006 ; 27 (21). 2516-2523 (Pubitemid 44627293)
19. Avkiran M, Marber MS. Na(+)/H(+) exchange inhibitors for cardioprotective therapy: progress, problems and prospects. J Am Coll Cardiol. 2002 ; 39 (5). 747-753 (Pubitemid 34185318)
20. Baran KW, Nguyen M, McKendall GR, et al. Double-blind, randomised trial of an anti-CD18 antibody in conjunction with recombinant tissue plasminogen activator for acute myocardial infarction: limitation of myocardial infarction following thrombolysis in acute myocardial infarction (LIMIT AMI) study. Circulation. 2001 ; 104 (23). 2778-2783 (Pubitemid 33126650)
21. Faxon DP, Gibbons RJ, Chronos NA, Gurbel PA, Sheehan F,. The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: the results of the HALT-MI study. J Am Coll Cardiol. 2002 ; 40 (7). 1199-1204
22. Tanguay JF, Krucoff MW, Gibbons RJ, et al. Efficacy of a novel P-selectin antagonist, rPSGL-Ig for reperfusion therapy in acute myocardial infarction: the RAPSODY trial. J Am Coll Cardiol. 2003 ; 41 (suppl). 404A
23. Mertens P, Maes A, Nuyts J, et al. Recombinant P-selectin glycoprotein ligandimmunoglobulin, a P-selectin antagonist, as an adjunct to thrombolysis in acute myocardial infarction: the P-Selectin Antagonist Limiting Myonecrosis (PSALM) trial. Am Heart J. 2006 ; 152 (1). e1-e8
24. Mahaffey KW, Granger CB, Nicolau JC, et al. Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial. Circulation. 2003 ; 108 (10). 1176-1183 (Pubitemid 37099984)
25. Granger CB, Mahaffey KW, Weaver WD, et al. Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the complement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial. Circulation. 2003 ; 108 (10). 1184-1190 (Pubitemid 37099985)
26. Armstrong PW, Granger CB, Adams PX, et al. Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: A randomised controlled trial. JAMA. 2007 ; 297 (1). 43-51 (Pubitemid 46041725)
27. Ross AM, Gibbons RJ, Stone GW, Kloner RA, Alexander RW. A randomised, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). J Am Coll Cardiol. 2005 ; 45 (11). 1775-1780 (Pubitemid 40779856)
28. Kloner RA, Forman MB, Gibbons RJ, Ross AM, Alexander RW, Stone GW. Impact of time to therapy and reperfusion modality on the efficacy of adenosine in acute myocardial infarction: the AMISTAD-2 trial. Eur Heart J. 2006 ; 27 (20). 2400-2405 (Pubitemid 44522145)
29. Zhao ZQ, Corvera JS, Halkos ME, et al. Inhibition of myocardial injury by ischaemic postconditioning during reperfusion: comparison with ischaemic preconditioning. Am J Physiol Heart Circ Physiol. 2003 ; 285 (2). H579-H588
30. Hausenloy DJ, Yellon DM. Remote ischaemic preconditioning: underlying mechanisms and clinical application. Cardiovasc Res. 2008 ; 79 (3). 377-386
31. Przyklenk K, Bauer B, Ov , ize M, Kloner RA, Whittaker P. Regional ischaemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation. 1993 ; 87 (3). 893-899 (Pubitemid 23070821)
32. Kharbanda RK, Mortensen UM, White PA, et al. Transient limb ischemia induces remote ischemic preconditioning in vivo. Circulation. 2002 ; 106 (23). 2881-2883 (Pubitemid 35424735)
33. Cheung MM, Kharbanda RK, Konstantinov IE, et al. Randomised controlled trial of the effects of remote ischaemic preconditioning on children undergoing cardiac surgery: first clinical application in humans. J Am Coll Cardiol. 2006 ; 47 (11). 2277-2282 (Pubitemid 43795071)
34. Zhou W, Zeng D, Chen R, et al. Limb ischemic preconditioning reduces heart and lung injury after an open heart operation in infants. Pediatr Cardiol. 2010 ; 31 (1). 22-29
35. Hausenloy DJ, Mwamure PK, Venugopal V, et al. Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial. Lancet. 2007 ; 370 (9587). 575-579 (Pubitemid 47247853)
36. Venugopal V, Hausenloy DJ, Ludman A, et al. Remote ischaemic preconditioning reduces myocardial injury in patients undergoing cardiac surgery with cold-blood cardioplegia: a randomised controlled trial. Heart. 2009 ; 95 (19). 1567-1571
37. Ali N, Rizwi F, Iqbal A, Rashid A. Induced remote ischemic pre-conditioning on ischemia-reperfusion injury in patients undergoing coronary artery bypass. J Coll Physicians Surg Pak. 2010 ; 20 (7). 427-431
38. Thielmann M, Kottenberg E, Boengler K, et al. Remote ischaemic preconditioning reduces myocardial injury after coronary artery bypass surgery with crystalloid cardioplegic arrest. Basic Res Cardiol. 2010 ; 105 (5). 657-664
39. Ali ZA, Callaghan CJ, Lim E, et al. Remote ischaemic preconditioning reduces myocardial and renal injury after elective abdominal aortic aneurysm repair: a randomised controlled trial. Circulation. 2007 ; 116 ((11 suppl)). I98-I105
40. Walsh SR, Boyle JR, Tang TY, et al. Remote ischaemic preconditioning for renal and cardiac protection during endovascular aneurysm repair: a randomised controlled trial. J Endovasc Ther. 2009 ; 16 (6). 680-689
41. Hoole SP, Heck PM, Sharples L, et al. Cardiac remote ischaemic preconditioning in coronary stenting (CRISP Stent) study: a prospective, randomised control trial. Circulation. 2009 ; 119 (6). 820-827
42. Rentoukas I, Giannopoulos G, Kaoukis A, et al. Cardioprotective role of remote ischaemic perconditioning in primary percutaneous coronary intervention: enhancement by opioid action. JACC Cardiovasc Interv. 2010 ; 3 (1). 49-55
43. Bøtker HE, Kharbanda R, Schmidt MR, et al. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet. 2010 ; 375 (9716). 727-734
44. Hong DM, Mint JJ, Kim JH, et al. The effect of remote ischaemic preconditioning on myocardial injury in patients undergoing off-pump coronary artery bypass graft surgery. Anaesth Intensive Care. 2010 ; 38 (5). 924-929
45. Rahman IA, Mascaro JG, Steeds RP, et al. Remote ischaemic preconditioning in human coronary artery bypass surgery: from promise to disappointment?. Circulation. 2010 ; 122 ((11 suppl)). S53-S59
46. Li L, Luo W, Huang L, Zhang W, et al. Remote perconditioning reduces myocardial injury in adult valve replacement: a randomized controlled trial. J Surg Res. 2010 Nov ; 164 (1). e21-e26
47. Walsh SR, Sadat U, Boyle JR, et al. Remote ischaemic preconditioning for renal protection during elective open infrarenal abdominal aortic aneurysm repair: randomised controlled trial. Vasc Endovascular Surg. 2010 ; 44 (5). 334-340
48. Walsh SR, Nouraei SA, Tang TY, Sadat U, Carpenter RH, Gaunt ME. Remote ischaemic preconditioning for cerebral and cardiac protection during carotid endarterectomy: results from a pilot randomised clinical trial. Vasc Endovascular Surg. 2010 ; 44 (6). 434-439
49. Iliodromitis EK, Kyrzopoulos S, Paraskevaidis IA, et al. Increased C reactive protein and cardiac enzyme levels after coronary stent implantation. is there protection by remote ischaemic preconditioning?. Heart. 2006 ; 92 (12). 1821-1826 (Pubitemid 44851332)
50. Hoole SP, Heck PM, White PA, et al. Remote ischaemic preconditioning stimulus does not reduce microvascular resistance or improve myocardial blood flow in patients undergoing elective percutaneous coronary intervention. Angiology. 2009 ; 60 (4). 403-411
51. Hoole SP, Khan SN, White PA, et al. Remote ischaemic pre-conditioning does not attenuate ischaemic left ventricular dysfunction in humans. Eur J Heart Fail. 2009 ; 11 (5). 497-505
52. Shimizu M, Tropak M, Diaz RJ, et al. Transient limb ischaemia remotely preconditions through a humoral mechanism acting directly on the myocardium: Evidence suggesting cross-species protection. Clin Sci (Lond). 2009 ; 117 (5). 191-200
53. Brener SJ, Lytle BW, Schneider JP, Ellis SG, Topol EJ. Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality. J Am Coll Cardiol. 2002 ; 40 (11). 1961-1967 (Pubitemid 35428831)
54. Kathiresan S, Servoss SJ, Newell JB, et al. Cardiac troponin T elevation after coronary artery bypass grafting is associated with increased one-year mortality. Am J Cardiol. 2004 ; 94 (7). 879-881 (Pubitemid 39349551)
55. Lehrke S, Steen H, Sievers HH, et al. Cardiac troponin T for prediction of short-and long-term morbidity and mortality after elective open heart surgery. Clin Chem. 2004 ; 50 (9). 1560-1567 (Pubitemid 39121224)
56. Mohammed AA, Agnihotri AK, van Kimmenade RR, et al. Prospective, comprehensive assessment of cardiac troponin T testing after coronary artery bypass graft surgery. Circulation. 2009 ; 120 (10). 843-850
57. Fellahi JL, Gue X, Richom , me X, Monier E, Guillou L, Riou B. Short-and long-term prognostic value of postoperative cardiac troponin i concentration in patients undergoing coronary artery bypass grafting. Anesthesiology. 2003 ; 99 (2). 270-274 (Pubitemid 36909551)
58. Croal BL, Hillis GS, Gibson PH, et al. Relationship between postoperative cardiac troponin I levels and outcome of cardiac surgery. Circulation. 2006 ; 114 (14). 1468-1475 (Pubitemid 44527001)
59. Muehlschlegel JD, Perry TE, Liu KY, et al. Troponin is superior to electrocardiogram and creatinine kinase MB for predicting clinically significant myocardial injury after coronary artery bypass grafting. Eur Heart J. 2009 ; 30 (13). 1574-1583
60. Heusch G, Schulz R, Haude M, Erbel R. Coronary microembolization. J Mol Cell Cardiol. 2004 ; 37: 23-31 (Pubitemid 38900525)
61. Landoni G, Bignami E, Oliviero F, Zangrillo A. Halogenated anaesthetics and cardiac protection in cardiac and non-cardiac anaesthesia. Ann Card Anaesth. 2009 ; 12 (1). 4-9
62. Steensrud T, Li J, Dai X, et al. Pretreatment with the nitric oxide donor SNAP or nerve transection blocks humoral preconditioning by remote limb ischemia or intra-arterial adenosine. Am J Physiol Heart Circ Physiol. 2010 ; 299 (5). H1598-H1603
63. Diehl JT, Cali RF, Hertzer NR, Beven EG. Complications of abdominal aortic reconstruction. an analysis of perioperative risk factors in 557 patients. Ann Surg. 1983 ; 197 (1). 49-56 (Pubitemid 13211723)
64. Haggart PC, Adam DJ, Ludman PF, Bradbury AW. Comparison of cardiac troponin I and creatine kinase ratios in the detection of myocardial injury after aortic surgery. Br J Surg. 2001 ; 88 (9). 1196-1200 (Pubitemid 34015603)
65. Barbagallo M, Casati A, Spadini E, et al. Early increases in cardiac troponin levels after major vascular surgery is associated with an increased frequency of delayed cardiac complications. J Clin Anesth. 2006 ; 18 (4). 280-285
66. Le Manach Y, Perel A, Coria , t P, Godet G, Bertrand M, Riou B. Early and delayed myocardial infarction after abdominal aortic surgery. Anesthesiology. 2005 ; 102 (5). 885-891 (Pubitemid 40590068)
67. McFalls EO, Ward HB, Moritz TE, et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med. 2004 ; 351 (27). 2795-2804 (Pubitemid 40051903)
68. Ellis SG, Hertzer NR, Young JR, Brener S. Angiographic correlates of cardiac death and myocardial infarction complicating major nonthoracic vascular surgery. Am J Cardiol. 1996 ; 77 (12). 1126-1128 (Pubitemid 126334755)
69. Wald R, Waikar SS, Liang , os O, Pereira BJ, Chertow GM, Jaber BL. Acute renal failure after endovascular vs open repair of abdominal aortic aneurysm. J Vasc Surg. 2006 ; 43 (3). 460-466
70. Brady AR, Fowkes FG, Greenhalgh RM, Powell JT, Ruckley CV, Thompson SG. Risk factors for postoperative death following elective surgical repair of abdominal aortic aneurysm: results from the UK Small Aneurysm Trial. Br J Surg. 2000 ; 87 (6). 742-749 (Pubitemid 30389274)
71. Porto I, Blackman DJ, Nicolson D, et al. What is the incidence of myocardial necrosis in elective patients discharged on the same day following percutaneous coronary intervention?. Heart. 2004 ; 90 (12). 1489-1490 (Pubitemid 39626339)
72. Nageh T, Sherwood RA, Harris BM, Thomas MR. Prognostic role of cardiac troponin i after percutaneous coronary intervention in stable coronary disease. Heart. 2005 ; 91 (9). 1181-1185 (Pubitemid 41192395)
73. Ramirez-Moreno A, Cardenal R, et al. Predictors and prognostic value of myocardial injury following stent implantation. Int J Cardiol. 2004 ; 97 (2). 193-198 (Pubitemid 39286835)
74. Kizer JR, Muttrej MR, Matthai WH, et al. Role of cardiac troponin T in the long-term risk stratification of patients undergoing percutaneous coronary intervention. Eur Heart J. 2003 ; 24 (14). 1314-1322 (Pubitemid 36917702)
75. Ricciardi MJ, Davidson CJ, Gubernikoff G, et al. Troponin I elevation and cardiac events after percutaneous coronary intervention. Am Heart J. 2003 ; 145 (3). 522-528 (Pubitemid 36390500)
76. Cantor WJ, Newby LK, Christenson RH, et al. Prognostic significance of elevated troponin I after percutaneous coronary intervention. J Am Coll Cardiol. 2002 ; 39 (11). 1738-1744 (Pubitemid 34595282)
77. Babu GG, Walker JM, Yellon DM, Hausenloy DJ. Peri-procedural myocardial injury during percutaneous coronary intervention: an important target for cardioprotection. Eur Heart J. 2011 ; 32 (1). 23-32
78. Hausenloy DJ, Baxter G, Bell R, et al. Translating novel strategies for cardioprotection: the hatter workshop recommendations. Basic Res Cardiol. 2010 ; 105 (6). 677-686